Your browser doesn't support javascript.
loading
Formulation, Characterization, Antioxidant, Cytotoxicity, and Anti-acute Leukemia Effects of Fe Nanoparticles.
Shen, JiaKun; Dong, Huijuan; Li, Chunyan; Yan, Jingxiu.
Afiliação
  • Shen J; Department of Hematology, Shangrao People's Hospital.
  • Dong H; Department of Hematology, Shangrao People's Hospital.
  • Li C; Department of Hematology, Shangrao People's Hospital.
  • Yan J; Department of Hematology, Shangrao People's Hospital.
J Oleo Sci ; 71(3): 387-394, 2022.
Article em En | MEDLINE | ID: mdl-35236798
In this study, iron nanoparticles were prepared and synthesized in aqueous medium using Cinnamomum verum as stabilizing and reducing agents. We determined the anti-acute leukemia potentials of FeNPs against acute T cell leukemia and acute lymphoblastic leukemia cell lines. FeNPs inhibited half of the DPPH molecules in the concentration of 139 µg/mL. MTT assay was used on J.RT3-T3.5 (Acute T cell leukemia cell line), Jurkat, Clone E6-1 (Acute T cell leukemia cell line), MOLT-3 (Acute lymphoblastic leukemia cell line), TALL-104 (Acute lymphoblastic leukemia cell line), and HUVEC (Normal cell line) for analyzing of cytotoxicity and anti-acute leukemia effects of FeNPs. These nanoparticles had high cell death and anti-acute leukemia effects against J.RT3-T3.5, Jurkat, Clone E6-1, MOLT-3, and TALL-104 cell lines. Among the above cell lines, the best result of anti-acute leukemia properties of composite was gained in the cell line of Jurkat, Clone E6-1. All result showed the iron nanoparticles may be used as a chemotherapeutic treatment drug of leukemia in humans.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia / Nanopartículas Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia / Nanopartículas Idioma: En Ano de publicação: 2022 Tipo de documento: Article